48,830
edits
(+ref) |
|||
Line 9: | Line 9: | ||
*[[Clear cell papillary renal cell tumour]] (previously [[clear cell papillary renal cell carcinoma]]). | *[[Clear cell papillary renal cell tumour]] (previously [[clear cell papillary renal cell carcinoma]]). | ||
*[[ELOC-mutated renal cell carcinoma]]. | *[[ELOC-mutated renal cell carcinoma]]. | ||
*RCC with mTOR pathway mutation.<ref>{{cite journal |authors=Shah RB, Mehra R |title=Renal Cell Carcinoma Associated With TSC/MTOR Genomic Alterations: An Update on its Expanding Spectrum and an Approach to Clinicopathologic Work-up |journal=Adv Anat Pathol |volume= |issue= |pages= |date=October 2023 |pmid=37899532 |doi=10.1097/PAP.0000000000000419 |url=}}</ref> | *[[RCC with TSC/mTOR pathway mutation]].<ref>{{cite journal |authors=Shah RB, Mehra R |title=Renal Cell Carcinoma Associated With TSC/MTOR Genomic Alterations: An Update on its Expanding Spectrum and an Approach to Clinicopathologic Work-up |journal=Adv Anat Pathol |volume= |issue= |pages= |date=October 2023 |pmid=37899532 |doi=10.1097/PAP.0000000000000419 |url=}}</ref> | ||
*[[Xp11.2 translocation carcinoma]]. | *[[Xp11.2 translocation carcinoma]]. | ||
*[[Epithelioid angiomyolipoma]].{{fact}} | *[[Epithelioid angiomyolipoma]].{{fact}} |
edits